• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Should we just let the anticoagulation service do it? The conundrum of anticoagulation for atrial fibrillation.

作者信息

Matchar D B, Samsa G P, Cohen S J

出版信息

J Gen Intern Med. 1996 Dec;11(12):768-70. doi: 10.1007/BF02598998.

DOI:10.1007/BF02598998
PMID:9016428
Abstract
摘要

相似文献

1
Should we just let the anticoagulation service do it? The conundrum of anticoagulation for atrial fibrillation.
J Gen Intern Med. 1996 Dec;11(12):768-70. doi: 10.1007/BF02598998.
2
Why isn't warfarin prescribed to patients with nonrheumatic atrial fibrillation?为什么不将华法林用于非风湿性心房颤动患者？
J Gen Intern Med. 1996 Dec;11(12):721-8. doi: 10.1007/BF02598985.
3
Recent national patterns of warfarin use in atrial fibrillation.近期全国范围内心房颤动患者使用华法林的情况
Circulation. 1998 Apr 7;97(13):1231-3. doi: 10.1161/01.cir.97.13.1231.
4
Quality of service provision for anticoagulation in atrial fibrillation. Many patients are ineligible.心房颤动抗凝治疗的服务质量。许多患者不符合条件。
BMJ. 1996 Jan 6;312(7022):51. doi: 10.1136/bmj.312.7022.51a.
5
Physician practices regarding anticoagulation and cardioversion of atrial fibrillation.医生关于心房颤动抗凝和复律的诊疗实践。
Arch Intern Med. 1996 Feb 12;156(3):290-4.
6
Failure to prescribe warfarin to patients with nonrheumatic atrial fibrillation.
J Gen Intern Med. 1996 Dec;11(12):713-20. doi: 10.1007/BF02598984.
7
Anticoagulation in elderly persons: a call for wider use.老年人的抗凝治疗：呼吁更广泛应用
Am Fam Physician. 1998 Jul;58(1):39-40, 42.
8
Anticoagulation in atrial fibrillation. Does efficacy in clinical trials translate into effectiveness in practice?
Arch Intern Med. 1994 Sep 12;154(17):1945-53. doi: 10.1001/archinte.154.17.1945.
9
Factors influencing physicians' reported use of anticoagulation therapy in nonvalvular atrial fibrillation: a cross-sectional survey.影响医生报告的非瓣膜性心房颤动抗凝治疗使用情况的因素：一项横断面调查。
Clin Ther. 2003 Jun;25(6):1750-64. doi: 10.1016/s0149-2918(03)80167-4.
10
Physicians' attitudes toward oral anticoagulants and antiplatelet agents for stroke prevention in elderly patients with atrial fibrillation.医生对老年房颤患者预防中风使用口服抗凝剂和抗血小板药物的态度。
Arch Intern Med. 1991 Oct;151(10):1950-3.

引用本文的文献

1
Patient and physician satisfaction with a telephone-based anticoagulation service.患者和医生对基于电话的抗凝服务的满意度。
J Gen Intern Med. 2001 Jul;16(7):460-3. doi: 10.1046/j.1525-1497.2001.016007460.x.
2
The outcomes of outcomes and effectiveness research: impacts and lessons from the first decade.结果与效果研究的成果：首个十年的影响与经验教训
Health Serv Res. 2000 Dec;35(5 Pt 1):977-93.
3
Community impact of anticoagulation services: rationale and design of the Managing Anticoagulation Services Trial (MAST).抗凝服务的社区影响：抗凝服务管理试验（MAST）的基本原理与设计

本文引用的文献

1
Why isn't warfarin prescribed to patients with nonrheumatic atrial fibrillation?为什么不将华法林用于非风湿性心房颤动患者？
J Gen Intern Med. 1996 Dec;11(12):721-8. doi: 10.1007/BF02598985.
2
Failure to prescribe warfarin to patients with nonrheumatic atrial fibrillation.
J Gen Intern Med. 1996 Dec;11(12):713-20. doi: 10.1007/BF02598984.
3
An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation.非风湿性心房颤动患者预防性抗凝的最低有效强度分析
J Thromb Thrombolysis. 2000 Jun;9 Suppl 1:S7-11. doi: 10.1023/a:1018722001817.
4
The cost-effectiveness of different management strategies for patients on chronic warfarin therapy.慢性华法林治疗患者不同管理策略的成本效益
J Gen Intern Med. 2000 Jan;15(1):31-7. doi: 10.1046/j.1525-1497.2000.01239.x.
N Engl J Med. 1996 Aug 22;335(8):540-6. doi: 10.1056/NEJM199608223350802.
4
The risk for and severity of bleeding complications in elderly patients treated with warfarin. The National Consortium of Anticoagulation Clinics.老年患者接受华法林治疗时出血并发症的风险及严重程度。全国抗凝诊所联盟。
Ann Intern Med. 1996 Jun 1;124(11):970-9. doi: 10.7326/0003-4819-124-11-199606010-00004.
5
US National Survey of Physician Practices for the Secondary and Tertiary Prevention of Ischemic Stroke. Carotid endarterectomy.美国缺血性中风二级和三级预防医师实践全国调查。颈动脉内膜切除术。
Stroke. 1996 May;27(5):801-6. doi: 10.1161/01.str.27.5.801.
6
Bleeding complications in oral anticoagulant therapy. An analysis of risk factors.口服抗凝治疗中的出血并发症。危险因素分析。
Arch Intern Med. 1993 Jul 12;153(13):1557-62. doi: 10.1001/archinte.153.13.1557.
7
Atrial fibrillation and anticoagulation: from randomised trials to practice.心房颤动与抗凝治疗：从随机试验到临床实践
Lancet. 1993 May 29;341(8857):1381-4. doi: 10.1016/0140-6736(93)90950-l.
8
Anticoagulation in atrial fibrillation. Does efficacy in clinical trials translate into effectiveness in practice?
Arch Intern Med. 1994 Sep 12;154(17):1945-53. doi: 10.1001/archinte.154.17.1945.
9
Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study).老年受试者中心房颤动的患病率（心血管健康研究）
Am J Cardiol. 1994 Aug 1;74(3):236-41. doi: 10.1016/0002-9149(94)90363-8.
10
Atrial fibrillation and stroke. Three new studies, three remaining questions.心房颤动与中风。三项新研究，三个遗留问题。
Arch Intern Med. 1994 Jul 11;154(13):1443-8.